Doran Ksienski

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Vanessa Bernstein, Susan Ellard, Susan Dent et al. · Breast Cancer Research and Treatment · 2017 · 97 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +9

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non–Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis

Doran Ksienski, Elaine S. Wai, Nicole S. Croteau et al. · Clinical Lung Cancer · 2018 · 89 citations

Adverse Events, Medicine, Retrospective Multicenter Analysis +8

Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC)

Doran Ksienski, Ryan Woods, Caroline Speers et al. · Annals of Surgical Oncology · 2010 · 44 citations

Surgical Oncology, Hepatology, Gastrointestinal Oncology +8

Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice

Doran Ksienski, Elaine S. Wai, Nicole S. Croteau et al. · Lung Cancer · 2019 · 44 citations

Medicine, Cancer Management, Pathology +8